medigraphic.com
Instituto Nacional de Neurología y Neurocirugía

2010, Number 1

<< Back Next >>

Arch Neurocien 2010; 15 (1)

Opioids in the management of pain in diabetic neuropathy

Moreno CB, Gutiérrez-Álvarez AM

Language: Spanish
References: 30
Page: 31-34
PDF size: 91.42 Kb.


ABSTRACT

Neuropathy is one of the most frequent complications of diabetes and pain, one of its more common and incapacitating symptoms. Recently there are reports of the use of opioids as an alternative of analgesic treatment. Objective: this work’sobjective has been to carry out a systematic review for determining the opioids power for managing pain in patients suffering from painful diabetic neuropathy. Methodology: a search and systematic selection was carried out of all clinical assays concerning the analgesic treatment of diabetic neuropathy using opioids published from January 1998 to June 2009. Randomized clinical trials compared with placebo were included which studied the analgesic effect of opioids in adults suffering from painful diabetic neuropathy; they were evaluated so that improvement of pain could be objectively classified. Results: there were nine randomized clinical trials identified. Only five were finally included: two with tramadol and three with oxycodone. The data provided by these studies did not allow to perform a meta-analysis. Conclusions: the improvement of pain in patients treated with tramadol or oxicodone was statistically significant superior when compared to placebo. It is necessary to make future clinical randomized studies to evaluate the analgesic effectiveness of opioids in painful diabetic neuropathy, including the magnitude of individual improvement, the previous definition of the percentage of improvement that is considered clinically significant and a longer time of follow-up.


REFERENCES

  1. Kelkar P. Diabetic neuropathy. Semin Neurol 2005;25(2):168-73.

  2. Schmader KE. Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy. Clin J Pain 2002;18(6):350-4.

  3. Gordois A, Scuffham P, Shearer A, Oglesby A, Tobian JA. The health care costs of diabetic peripheral neuropathy in the US. Diabetes Care 2003;26(6):1790-5.

  4. Sinnreich M, Taylor BV, Dyck PJB. Diabetic Neuropathies. Classification, clinical features and pathophysiological basis. Neurologist 2005;11(2):63-79.

  5. Vinik AI. Diabetic neuropathy: pathogenesis and therapy. Am J Med 1999;107(2B):17S-26S.

  6. Gutiérrez-Alvarez AM, Beltrán-Rodríguez JA, Moreno CB. Antiepileptics in pain caused by diabetic neuropathy. J Pain Symptom Manage 2007;34(2):201-8.

  7. Jackson II KC. Pharmacotherapy for neuropathic pain. Pain Pract 2006;6(1):27-33.

  8. Dworkin RH, O’Connor AB, Backonja M, Farrar JT, Finnerup NB, Jensen TS, Kalso EA, Loeser JD, Miaskowski C, Nurmikko TJ, Portenoy RK, Rice AS, Stacey BR, Treede. RD, Turk DC, Wallace MS. Pharmacólogic management of neuropathic pain: evidencebased recommendations. Pain 2007;132(3):237-51.

  9. Eisenberg E, McNicol E, Can DB. Opioids for neuropathic pain. Cochrane Database Syst Rev 2006;3:CD006146.

  10. Harati Y, Gooch C, Swenson M, Edelman S, Greene D, Raskin P, et al. Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology 1998;50(6):1842-6.

  11. Sindrup SH, Andersen G, Madsen C, Smith T, Br, sen K, Jensen TS. Tramadol relieves pain and allodynia in polyneuropathy: a randomized, double-blind, controlled trial. Pain 1999;83:85-90.

  12. Harati Y, Gooch C, Swenson M, Edelman SV, Greene D, Raskin P, et al. Maintenance of the long-term effectiveness of tramadol in treatment of the pain of diabetic neuropathy. J Diabetes Complicat 2000;14:65-70.

  13. Gimbel JS, Richards P, Portenoy RK. Controlled-release oxycodone for pain in diabetic neuropathy. A randomized controlled trial. Neurology 2003;60:927-34.

  14. Watson CPN, Moulin D, Watt-Watson J, Gordon A, Eisenhoffer J. Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy. Pain 2003;105:71-8.

  15. Gilron I, Bailley JM, Tu D, Holden RR, Weaver DF, Houlden RL. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med 2005;352:1324-34.

  16. Freeman R, Raskin P, Hewitt DJ, Vorsanger GJ, Jordan DM, Xiang J, et al. Randomized study of tramadol/acetaminophen versus placebo in painful diabetic peripheral neuropathy. Curr Med Res Opin 2007;23(1):147-61.

  17. Simpson DM, Messina J, Xie F, Hale M. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, doubleblind, placebo-controlled study. Clin Ther 2007;29(4):588-601.

  18. Hanna MÓ; “Brien C, Wilson MC. Prolonged-release oxycodone enhances the effects of existing gabapentin therapy in painful diabetic neuropathy patients. Eur J Pain 2008;12:804-13.

  19. Adriaensen H, Plaghki L, Mathieu C, Joffroy A, Vissers K. Critical review of oral drug treatments for diabetic neuropathic pain - clinical outcomes based on efficacy and safety data from placebocontrolled and direct comparative studies. Diabetes Metab Res Rev 2005;21:231-40.

  20. Argoff CE, Backonja MM, Belgrade MJ, Bennett GJ, Clark MR, Cole BE, et al. Consensus guidelines: treatment planning and options. Mayo Clinic Proc 2006;81(4 suppl):S12-S25.

  21. Guirguis-Blake J, Kelly C. Are opioids effective in the treatment of neuropathic pain? Am Fam Physician 2007;75(7):999-1001.

  22. Chong MS, Hester J. Diabetic painful neuropathy current and future treatment options. Drugs 2007;67(4):569-85.

  23. McKeage K. Treatment options for the Management of diabetic painful neuropathy: best current evidence. Curr Opin Neurol 2007;20:553-7.

  24. Wong MC, Chung JW, Wong TK. Effects of treatments for symptoms of painful diabetic neuropathy: systematic review. BMJ 2007;335(7610):87.

  25. Raffa RB, Friderichs E, Reimann W, Shank RP, Codd EE, Vaught JL. Opioid and nonopioid components independently contribute to the mechanism of action tramadol, an “atypical” opioid analgesic. J Pharmacol Exp Ther 1992;260:275-85.

  26. Berrocoso E, Mico JA, Ugedo L. In vivo effect of tramadol on locus coeruleus neurons is mediated by alpha 2-adrenocpetors and modulated by serotonina. Neuropharmacology 2006;51:146-53.

  27. Haeseler G, Foadi N, Ahrens J2 Dengler R, Hecker H, Leuwer M. Tramacrol, fentanyl_aid sufentanyl but not morphine block voltageoperated sodium channels. Pain 2006;126:234-44.

  28. Tsai TY, Tsai YC, Wu SN, Liu YC. Tramadol-induced blockade of delayed rectified potassium current in NG 108-15 neuronal cells. Eur J Pain 2006;10:597-601.

  29. Hara K, Minami K, Sata T. The effects of tramadol and its metabolite on glycine, gamma-aminobutyric acid, and N-methyl-D-aspartatereceptors expressed in Xenopus oocytes. Anesth Analg 2005;100:1400-5.

  30. Marincsák R, Tóth BI, Czifra G, Szabó T, Kovács L, Bíró T. The analgesic drug, tramadol, acts as an agonist of the transient receptor potential vanilloid-1. Anesth Analg 2008;106:1890-6.




2020     |     www.medigraphic.com